KR20190084229A - Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof - Google Patents
Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof Download PDFInfo
- Publication number
- KR20190084229A KR20190084229A KR1020190080880A KR20190080880A KR20190084229A KR 20190084229 A KR20190084229 A KR 20190084229A KR 1020190080880 A KR1020190080880 A KR 1020190080880A KR 20190080880 A KR20190080880 A KR 20190080880A KR 20190084229 A KR20190084229 A KR 20190084229A
- Authority
- KR
- South Korea
- Prior art keywords
- pork
- betaine
- fatty acids
- omega
- processed meat
- Prior art date
Links
- 235000015277 pork Nutrition 0.000 title claims abstract description 69
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 57
- 239000000194 fatty acid Substances 0.000 title claims abstract description 57
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 57
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 57
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 title claims abstract description 52
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 title claims abstract description 52
- 229960003237 betaine Drugs 0.000 title claims abstract description 52
- 235000020991 processed meat Nutrition 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 17
- 235000004426 flaxseed Nutrition 0.000 claims description 32
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 24
- 235000013580 sausages Nutrition 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003674 animal food additive Substances 0.000 claims 1
- 210000001015 abdomen Anatomy 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 41
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 18
- 239000006041 probiotic Substances 0.000 description 15
- 235000018291 probiotics Nutrition 0.000 description 15
- 241000282887 Suidae Species 0.000 description 12
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 10
- 235000010724 Wisteria floribunda Nutrition 0.000 description 9
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 9
- 229940033080 omega-6 fatty acid Drugs 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 7
- 230000037213 diet Effects 0.000 description 7
- 229940012843 omega-3 fatty acid Drugs 0.000 description 7
- 244000144972 livestock Species 0.000 description 6
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 239000006014 omega-3 oil Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000021342 arachidonic acid Nutrition 0.000 description 4
- 229940114079 arachidonic acid Drugs 0.000 description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 235000013622 meat product Nutrition 0.000 description 4
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 4
- 150000003180 prostaglandins Chemical class 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/302—Betaine, trimethylglycine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Description
본 발명은 아마종실과 베타인을 이용한 오메가 지방산의 균형과 기능성 물질이 강화된 돈육 및 가공육 생산과 그 생산방법에 관한 것이다.The present invention relates to the balance of omega fatty acids using flax seed and betaine, and the production of pork and processed meat reinforced with functional materials, and a production method thereof.
최근 육식의 위험성에 대한 많은 언론보도들이 있으면서 육식이 건강에 해롭다는 인식이 퍼지고 있으며 그 중 하나가 과도한 옥수수 사료로 인한 육제품 내 과도한 오메가-6 지방산의 축적으로 인한 오메가-3: 오메가-6 지방산 균형의 불균형이다. 이러한 오메가 지방산의 불균형을 해소하기 위하여 여러 방법이 존재하며 오메가-3 지방산 원료 중 축산에 사용하기에 적합한 경제성을 갖춘 것은 ALA원료인 아마종실과 들깨가 있다. Recently, there has been a lot of media reports about the risk of carnivorous spreading the perception that meat eating is harmful to health, one of which is omega-3: omega-6 fatty acids due to the accumulation of excessive omega-6 fatty acids in meat products due to excessive corn feed It is an imbalance of balance. There are various methods to overcome the imbalance of omega fatty acids. Omega-3 fatty acid sources are suitable for use in livestock production.
지금까지 시중에서 판매되고 있는 돈육은 오메가-6 지방산이 오메가-3 지방산에 비해 60배 높게 함유되어 있는 것으로 알려져 있다. 이러한 오메가-6 지방산은 각종 생리적 질병을 일으키는 원인으로 되고 있으며, 이 때문에 의식적으로 돈육을 기피하는 경향이 있었다. 오메가-6 지방산인 리놀레산은 아라키돈산으로 대사되며, 아라키돈산은 다시 체내조직의 세포막에서 대사되어 강한 생리활성을 갖는 아라키돈산 대사산물이 생성된다. 그리하여 오메가-6 지방산의 과잉섭취에 의해 생성된 각종 대사산물, 즉 아이코사노이드(Icosanoid)인 2-계열의 프로스타그란딘류(Prostaglandins)와, 4-계열의 류코 트리엔류(Leukotriens)는 동맥경화증, 고혈압, 심근경색증, 심빈혈, 혈전증, 심장병, 골수염, 피부병과 같은 각 종 생리적 질환을 유발시키는 것으로 알려져 있다. It is known that omega-6 fatty acids are 60 times higher than omega-3 fatty acids. These omega-6 fatty acids are responsible for various physiological diseases, which tend to consciously avoid pork. Linoleic acid, which is an omega-6 fatty acid, is metabolized to arachidonic acid, and arachidonic acid is metabolized again in the cell membrane of body tissue to produce arachidonic acid metabolite with strong physiological activity. Thus, various metabolites produced by the over-consumption of omega-6 fatty acids, namely the Icosanoid 2-family Prostaglandins and the 4-family Leukotriens, Hypertension, myocardial infarction, deep vein thrombosis, thrombosis, heart disease, osteomyelitis, skin diseases, and the like.
한편, 오메가-3 지방산, 예를 들면 리놀렌산은 체내조직의 세포막에서 사슬 연장 효소 및 불포화 효소(elongase 및 desaturase)에 의해서 일부가 아이코사펜타에노산(EPA)으로 전환되며, 이렇게 전환된 EPA는 리놀레산이 아라키돈산으로 전환되는 것과 아라키돈산이 아이코사노이드로 전환되는 것을 차단함과 동시에 대사를 통하여 3-계열의 프로스타글란딘류와 5-계열의 류코트리엔류를 생성한다. 그리하여 3-계열의 프로스타글란딘류와 5-계열의류코트리엔류는 아라키돈산의 대사산물인 2-계열의 프로스타글란딘류와 4-계열의 류코트리엔류의 생성을 차단하며, 이들에 의한 각종 생리적 질병을 예방 및 치료할 뿐만 아니라, 오메가-3 지방산 자체도 오메가-6 지방산의 대사경로를 차단하여 오메가-6 지방산에 의한 아이코사노이드의 생성을 저해한다. 그러나 이러한 오메가-3 지방산은 사람의 생체 내에서 합성되는 양이 매우 적고, 대사속도 역시 매우 빨라 인체 내에는 극소량만이 존재한다.On the other hand, omega-3 fatty acids such as linolenic acid are partly converted to icosapentaenoic acid (EPA) by chain extension enzymes and desaturases in the cell membrane of the body tissues, This inhibits the conversion of arachidonic acid and arachidonic acid into icosanoids, and at the same time, metabolism leads to the formation of 3-system prostaglandins and 5-system leucotrienes. Thus, the 3-system prostaglandins and the 5-system leucotrienes block the production of 2-system prostaglandins and 4-system leucotrienes, which are metabolites of arachidonic acid, and prevent or treat various physiological diseases caused by them In addition, the omega-3 fatty acids themselves block the metabolic pathway of omega-6 fatty acids and thus inhibit the production of isocona- nides by omega-6 fatty acids. However, these omega-3 fatty acids are synthesized in vivo in humans and have very low metabolic rate, so only very small amounts exist in the human body.
생리활성물질의 하나인 베타인은 체내에서 methionine, carnitine, creatine 등의 생리활성 물질로 전변이 가능하며 혈압강하, 항혈당작용, 지방간 치료 및 해독작용, 혈중 콜레스테롤 농도 저하 등의 효과가 있는 것으로 알려져 있다. 또한, 축산 분야에서는 가축의 여름철 고온 스트레스를 저감하기 위한 원료로 사용되고 있다. 또한 전 세계적으로 가축 사료 내 항생제 첨가가 금지되고 있으며 국내에서도 2011년 7월부터 가축 사료 내 성장촉진용 항생제의 혼합이 금지됨으로써 효과적인 항생제 대체제의 개발이 필요한 상황이며, 생균제는 병원성 미생물에 항균력을 가진 유산균 등을 활용하여 가장 효과적인 항생제 대체제로써 각광받고 있다. Betaine, one of the physiologically active substances, is known to be effective as a physiologically active substance such as methionine, carnitine, and creatine in the body and has effects of lowering blood pressure, antihyperglycemia, treatment and detoxification of fatty liver, and lowering of blood cholesterol level . In the livestock sector, livestock has been used as a raw material for reducing high temperature stress in summer. In addition, the addition of antibiotics in livestock feeds is prohibited globally, and since the mixing of antibiotics for promoting growth in livestock feeds is prohibited in Korea in July 2011, it is necessary to develop an effective antibiotic substitute, and the probiotic has antibacterial activity against pathogenic microorganisms Lactobacillus is the most effective antibiotic substitute.
그러나 현재까지 아마종실과 베타인을 첨가한 사료를 급여하여 오메가 지방산의 균형을 맞추고 베타인을 강화시킨 돈육 및 가공육과 그 생산방법에 대하여는 공지된 바 없다.However, there is no known pork and processed meat and their production methods, which have been supplemented with feedstuffs containing flax seed and betaine to balance omega fatty acids and fortify betaine.
따라서, 본 발명의 목적은 돈육이 가지고 있는 문제점인 과도한 오메가-6 지방산 축적으로 인한 오메가 지방산 불균형을 해결하고자 아마종실을 이용하여 오메가 지방산의 균형을 맞추고 베타인을 강화시켜 만든 기능성 돈육을 생산하는 데 있다. 본 발명의 다른 목적은 오메가 지방산의 균형과 베타인을 강화시킨 기능성 가공육 생산방법을 제공하는 데 있다.Accordingly, an object of the present invention is to produce omega fatty acid imbalance due to excessive accumulation of omega-6 fatty acids, which is a problem of pork, and to produce functional pork made by fortifying omega fatty acids and fortifying betaine using flax seeds . Another object of the present invention is to provide an omega fatty acid balance and a method for producing functional processed meat fortified with betaine.
본 발명의 상기 목적은 비육돈의 사료에 복합생균제, 베타인, 아마종실을 첨가하여 급여하는 단계와; 상기 복합생균제, 베타인, 아마종실을 첨가한 사료를 급여한 비육돈의 돈육 및 가공육 내 오메가 지방산 및 기능성 물질 함량 분석하는 단계로 이루어지고, 상기 결과를 토대로 오메가 지방산의 균형과 베타인을 강화시킨 기능성 돈육을 생산하고 그 생산방법을 제공함으로써 달성하였다.The above object of the present invention can be accomplished by a method of preparing a feed for a finishing pig, comprising the steps of: feeding a feed of a finishing pig by adding a compounding probiotics, betaine, and flaxseed; The present invention relates to a method for analyzing the content of omega fatty acids and functional materials in pork and processed meat of finishing pigs fed diets supplemented with the compound probiotics, betaine, and flax seeds. Based on the results, And by providing the production method.
본 발명 오메가 지방산의 균형과 베타인을 강화시킨 돈육 생산 및 그 생산방법에 관한 것으로 상기 오메가 지방산 균형과 베타인을 강화시킨 사료를 급여함으로써 비육돈의 성장 단계에서 여름철 고온 스트레스 저감 및 다양한 생리활성 효과를 기대할 수 있다. 또한, 오메가 지방산의 균형이 맞으면서 베타인이 가지고 있는 생리적인 기능성을 돈육 내 축적함으로써 육제품을 섭취하는 소비자에게 전달할 수 있는 뛰어난 효과가 있다. The present invention relates to the balance of omega fatty acids and to the production of pork fortified with betaine and the method of producing the same, wherein the omega fatty acid balance and betaine-fortified feed are fed, have. In addition, when the balance of omega fatty acids is balanced, the physiological functionality of betaine is accumulated in the pork, which has an excellent effect of being able to be delivered to consumers who consume meat products.
도 1은 아미종박, 베타인 및 비타민 E를 첨가한 사료를 급여하여 생리활성 물질 고함유 기능성 원료육을 생산방법을 나타낸 모식도이다.
도 2는 상기 사료를 58일 또는 68일 급여한 돈육(삼겹살)의 오메가 지방산 비율을 나타낸 그래프이다.
도 3은 상기 사료를 58일 또는 68일 급여한 돈육(후지)의 오메가 지방산 비율을 나타낸 그래프이다.
도 4는 상기 사료를 33일 급여한 돈육 내 베타인 함량을 나타낸 그래프이다.
도 5는 상기 사료를 33일 급여 한 비육돈의 혈청 내 베타인 함량을 나타낸 그래프이다.
도 6은 상기 사료를 33일 급여 한 비육돈의 혈청 내 homocysteine의 함량을 나타낸 그래프이다.
도 7은 상기 사료를 68일 급여 가공육의 오메가 지방산 비율을 나타낸 그래프이다.
도 8은 상기 사료를 68일 급여 가공육의 베타인 함량을 나타낸 그래프이다.
도 9는 상기 사료를 33일 급여 가공육의 베타인 함량을 나타낸 그래프이다.Fig. 1 is a schematic view showing a method of producing a raw material having high physiologically active content by feeding a feed supplemented with rice root, betaine and vitamin E;
FIG. 2 is a graph showing the proportion of omega fatty acids in pork (pork belly) fed with the feed for 58 days or 68 days.
3 is a graph showing the proportion of omega fatty acids in pork (Fuji) fed with the feed for 58 days or 68 days.
4 is a graph showing the content of betaine in the pork fed the feed for 33 days.
FIG. 5 is a graph showing the content of betaine in serum of finishing pigs fed the diet for 33 days.
6 is a graph showing the content of homocysteine in the serum of the finishing pig fed with the feed for 33 days.
FIG. 7 is a graph showing the ratio of omega fatty acid in the processed meat fed with the feed for 68 days.
FIG. 8 is a graph showing the content of betaine in the processed meat fed the diet for 68 days.
FIG. 9 is a graph showing the content of betaine in the processed meat fed the diet for 33 days.
본 발명은 오메가 지방산의 균형을 맞추고 베타인을 강화시킨 돈육, 원료육 및 가공육과 그 생산방법을 제공한다.The present invention provides pork, raw meat, processed meat, and a method for producing omega-3 fatty acids and betaine-fortified pork.
본 발명에 따르면 오메가-3 지방산인 ALA의 공급원으로 축산에서 사용하기에 적합한 아마종실을 이용하여 오메가 지방산 균형을 맞추고 베타인을 사료 내 첨가함으로써, 돼지의 성장단계에서 고온 스트레스 저감 및 다양한 생리활성 효과를 나타내며, 돈육 내 축적시킴으로써 오메가 지방산의 균형이 맞고 베타인이 가지고 있는 생리적인 기능성을 육제품을 섭취하는 소비자들에게 전달할 수 있다.According to the present invention, omega fatty acid balance is adjusted by using flax seeds suitable for use in livestock as a source of ALA as an omega-3 fatty acid, and betaine is added in the feed to reduce stress at the high temperature and various physiological activity effects By accumulating in pork, omega fatty acids can be balanced and the physiological functionality of Betaine can be passed on to consumers who consume meat products.
상기 육제품은 돈육, 원료육 및 가공육으로 제공 가능하며, 예를 들어 삼겹살과 같은 선호부위와 후지를 이용한 가공 육제품인 햄 및 소시지 등으로 제조할 수 있다.The meat products can be provided as pork, raw meat, and processed meat, and can be produced, for example, from ham and sausage, which are processed meat products using the preferred parts such as pork belly and fuji.
본 발명은 하기의 구체적인 실시 예와 시험 예에 의해 보다 구체적으로 설명되나, 하기 실시 예와 시험 예는 본 발명을 예시하기 위한 것으로 본 발명의 권리범위가 이에 한정하는 것으로 의도되지는 않는다. The present invention will be described in more detail with reference to the following specific examples and test examples. However, the following examples and test examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
실시예1. 시험사료의 준비Example 1. Preparation of test diets
본 실험에 사용된 기초사료의 배합비와 성분은 하기 표1에 나타난 바와 같으며, 상기 기초사료를 대조구로 하고 상기 대조구에 기초사료의 전체중량 대비 복합생균제 0.1중량%, 베타인 0.5중량% 및 아마종실 Nutex85를 2.5 내지 5중량%를 각각 첨가하여 시험사료로 사용하였다.The compounding ratios and ingredients of the basic feeds used in the experiment are shown in Table 1 below. The basic feeds were used as a control, and 0.1% by weight of the compound probiotics, 0.5% by weight of betaine, 2.5 to 5% by weight of seedling Nutex85 was added to each of them and used as a test feed.
실시예2. 비육돈 급여시험 1.시험기간 및 장소 : 2015년 5월 15일 ~ 7월 23일 전남 강진 자연농장Example 2. Fryer
공시축 : 4개월령 147두(3시험구) : 58일 또는 68일 급여 후 도축Disclosure axis: 147 months (4 test months): 58 days or 68 days after slaughter
본 발명 상기 실시예1의 방법으로 제조한 아마종실과 베타인을 첨가한 사료를 4개월령 비육돈에 각각 58일 또는 68일 동안 급여하였다. 하기 표2와 같이 시험구1에 복합생균제 0.1%, 베타인 0.5% 및 아마종실 Nutex85 2.5% 첨가하였고, 시험구2에는 복합생균제 0.1%, 베타인 0.5% 및 아마종실 Nutex85 5%를 첨가하였다. 대조구로는 복합생균제, 베타인 및 아마종실 Nutex85를 첨가하지 않은 사료를 급여한 구를 사용하였다.The flaxseed and betaine-fed diets prepared according to the method of Example 1 of the present invention were fed to the 4 month-old pigs for 58 days or 68 days, respectively. As shown in Table 2, 0.1% of the conjugative probiotics, 0.5% of betaine and 2.5% of flax seed Nutex 85 were added to
52
49
실시예3. 비육돈 급여시험 2.시험기간 및 장소 : 2015년 9월 17일 ~ 10월 20일 추풍령 이지바이오 시험농장Example 3. Farmer's
공시축 : 비육돈 5개월령 38두(3시험구) : 33일 급여 후 도축Disclosure axis: Finishing
본 발명 상기 실시예1의 방법으로 제조한 아마종실과 베타인을 첨가한 사료를 단기 급여에 따른 오메가 지방산 및 기능성 물질 함량에 미치는 효과를 확인하기 위해 5개월령 비육돈에 33일 동안 급여하였다. 하기 표4와 같이 시험구1에 복합생균제 0.1%, 베타인 0.5% 및 아마종실 Nutex85 2.5% 첨가하였고, 시험구2에는 복합생균제 0.1%, 베타인 0.5% 및 아마종실 Nutex85 5%를 첨가하였다. 또, 비타민을 시험구 1 및 2 모두 각각 0.6%씩 첨가하였다. 대조구로는 복합생균제, 베타인, 아마종실 Nutex85 및 비타민을 첨가하지 않은 사료를 급여한 구를 사용하였다.In order to confirm the effects of flaxseed and betaine prepared by the method of Example 1 on the content of omega fatty acid and functional material according to short-term feeding, they were fed to a 5-month-old finishing pig for 33 days. As shown in Table 4, 0.1% of the conjugative probiotics, 0.5% of betaine and 2.5% of flaxseed Nutex 85 were added to
(사료중량 %)Addition amount
(Feed weight%)
Test1
13
(10% 원료)
Vitamin E 0.6%
(10% raw material)
Test2
12
시험예1. 돈육 내 오메가 지방산 및 기능성 물질 함량 분석본 발명 상기 실시예2의 방법에 따라 아미종실과 베타인을 첨가한 사료를 58일 급여한 1차 돈육과 68일 급여한 2차 돈육 내 오메가 지방산 함량을 확인하기 위해 GC 분석 방법을 이용하여 분석하였다. Test Example 1 Analysis of Omega Fatty Acid and Functional Substance Content in Pork According to the method of Example 2 of the present invention, the content of omega fatty acid in the first pork fed 58 days and the second pork fed 68 days Were analyzed using the GC analysis method.
이를 평가하기 위해 돈육을 그룹별로 5두씩 무작위로 선택하여 돈육 샘플 약 100g씩을 도축장에서 예냉 후 채취하여 분석하였다. 시료 내 지방산은 GC를 이용하여 분석하였다.To evaluate this, 5 pork groups were randomly selected for each group, and about 100 g of pork samples were precooled and collected at the slaughterhouse. Fatty acids in the samples were analyzed by GC.
시험 결과, 도 2에서 알 수 있듯이 돈육 내 오메가 지방산의 비율(ω-6/ω-3)은 각 시험구의 1차 돈육과 2차 돈육 모두 대조구보다 낮게 나타났다. 1차 돈육 중 삼겹살 오메가 지방산 비율은 22.71:1에서 아마종실 2.5% 투여구에서는 7.27:1로, 5% 투여구에서는 6.5:1로 개선되었고, 2차 돈육 중 삼겹살 오메가 지방산 비율은 22.71:1에서 아마종실 2.5% 투여구에서는 4.3:1로, 5% 투여구에서는 3.86:1로 개선되었다.As a result of the test, as shown in FIG. 2, the ratio (ω-6 / ω-3) of the omega fatty acid in the pork was lower than that of the control pork in both the first pork and the second pork. The ratio of pork belly omega fatty acid in primary pork was improved from 22.71: 1 to 7.27: 1 in flax seed 2.5% and 6.5: 1 in 5% treatment pork. The ratio of pork belly omega fatty acid in secondary pork was 22.71: 1 It was improved to 4.3: 1 in flax seed 2.5% treatment and 3.86: 1 in 5% treatment.
또, 도3에서 알 수 있듯이 돈육 내 후지 오메가 지방산의 비율(ω-6/ω-3)은 각 시험구의 1차 돈육 및 2차 돈육 모두 대조구 보다 낮게 나타났다. 1차 돈육 중 후지 오메가 지방산 비율은 32.68:1에서 아마종실 2.5% 투여구에서는 10.15:1로, 5% 투여구에서는 7.41:1로 개선되었고, 2차 돈육 중 후지 오메가 지방산 비율은 32.68:1에서 아마종실 2.5% 투여구에서는 11.25:1로, 5% 투여구에서는 7.07:1로 개선되었다.As can be seen from Fig. 3, the ratio (ω-6 / ω-3) of the fujimo omega fatty acid in the pork was lower than that of the control pork in both the first pork and the second pork. The ratio of Fuji omega fatty acids in primary pork was improved from 32.68: 1 to 10.15: 1 in flax seed 2.5%, and 7.41: 1 in 5% treatment, and the proportion of fugi omega fatty acids in secondary pork was 32.68: 1 It was improved to 11.25: 1 in the flax seed 2.5% treatment group and to 7.07: 1 in the 5% treatment group.
시험예2. 돈육 내 오메가 지방산 및 기능성 물질 함량 분석Test Example 2 Analysis of Omega Fatty Acid and Functional Substance Content in Pork
본 발명 상기 실시예3의 방법에 따라 아마종실과 베타인을 첨가한 사료를 33일 급여한 비육돈의 돈육 내 오메가 지방산 및 기능성 물질 함량을 확인하기 위해 GC 분석 방법과 LC-MS를 이용하여 분석하였다. According to the method of Example 3 of the present invention, the content of omega fatty acids and functional substances in the pork of the finishing pigs fed the flaxseed and betaine-added feeds for 33 days was analyzed by GC analysis and LC-MS.
이를 평가하기 위해 비육돈을 5두씩 무작위로 선택하여 돈육 샘플 약 100g씩을 도축장에서 예냉 후 채취하여 분석하였다. 시료 내 지방산은 GC를 이용하여 분석하였고 베타인 및 homocysteine은 LC-MS를 이용하여 분석하였다.Five pigs were randomly selected for evaluation and 100 g of pork samples were precooled and collected at the slaughterhouse. Fatty acids in the samples were analyzed by GC and beta-phosphorus and homocysteine were analyzed by LC-MS.
시험 결과, 하기 표6에서 알 수 있듯이 돈육 내 오메가 지방산의 비율(ω-6/ω-3)은 33일 급여한 돈육은 대조구보다 낮게 나타났다. 돈육 중 삼겹살 오메가 지방산 비율은 22.2:1에서 아마종실 2.5% 투여구에서는 11.3:1로, 5% 투여구에서는 6.1:1로 개선되었고, 2차 돈육 중 후지 오메가 지방산 비율은 32:1에서 아마종실 2.5% 투여구에서는 14.8:1로, 5% 투여구에서는 8.5:1로 개선되었다.As a result of the test, the ratio (ω-6 / ω-3) of the omega fatty acids in the pork was lower than that of the control pork fed on the 33rd day, as shown in Table 6 below. The ratio of porkbone omega fatty acid in pork was improved from 11.2: 1 in flaxseed 2.5% to 6.1: 1 in 5% pork, and the ratio of fugi omega fatty acid in pork was 32: The dose was 14.8: 1 for the 2.5% dose group and 8.5: 1 for the 5% dose group.
또, 도4에서 알 수 있듯이 돈육 내 베타인 함량은 대조구에 비해 증가하였다. 돈육 중 목살의 베타인 함량은 97.1ug/g에서 427.1ug/g으로 약 4.4배 증가하였고 돈육 중 후지의 베타인 함량은 78.6ug/g에서 325.1ug/g으로 약 4.1배 증가하였다. 그리고 도5에서 알 수 있듯이 혈청 내 베타인 함량은 18.8ug/mL에서 79.7ug/mL로 약 4.2배 증가하였고 도6에서 알 수 있듯이 혈청 내 homocysteine 함량은 18.3ng/mL에서 14.8ng/mL로 약 19% 감소하였다.As can be seen from FIG. 4, the content of betaine in the pork was increased compared to that of the control. The content of betaine in the pork meat was increased from 97.1 ug / g to 427.1 ug / g, which was about 4.4 times. The content of betaine in the pork was increased from 78.6 ug / g to 325.1 ug / g. As can be seen from FIG. 5, the content of betaine in the serum was increased from 18.8 μg / mL to 79.7 μg / mL by about 4.2 times. As shown in FIG. 6, the homocysteine content in serum was 18.3 ng / mL to 14.8 ng / mL Respectively.
시험예3. 가공육 내 오메가 지방산 및 기능성 물질 함량 분석본 발명 상기 실시예2의 방법에 따라 아마종실과 베타인을 첨가한 사료를 68일 급여한 비육돈의 가공육 내 오메가 지방산 및 기능성 물질 함량을 확인하기 위해 GC 분석 방법과 LC-MS를 이용하여 분석하였다.Test Example 3. Analysis of Omega Fatty Acid and Functional Substance Content in the Processed Meat In order to determine the content of omega fatty acid and functional material in the finishing meat of the finishing pigs fed the feed containing flax seed and betaine according to the method of Example 2, And analyzed using LC-MS.
이를 평가하기 위해 상기 시험예1의 시험구2 돈육과 지방을 이용하여 햄(후지돈육 : 73.35%, 지방 : 16.29% 및 기타부재료 : 10.36%)과 소시지(후지돈육 : 53.79%, 지방 : 21.19% 및 기타부재료 : 22.02%)를 제조하여 오메가 지방산과 기능성 물질 함량을 분석하였다. 시료 내 지방산은 GC를 이용하여 분석하였고 베타인, homocysteine 및 비타민 E는 LC-MS를 이용하여 분석하였다.(Fuji pork: 73.35%, fat: 16.29% and other materials: 10.36%) and sausage (Fuji pork: 53.79%, fat: 21.19%) were used in the
시험 결과, 표7, 표8 및 도7에서 알 수 있듯이 68일 급여한 비육돈의 가공육 내 오메가 지방산 비율은 대조구에 비해 감소하였다. 햄의 오메가 지방산 비율은 16.23:1에서 3.63:1로 감소하였고 소시지의 오메가 지방산 비율은 16.31:1에서 3.8:1로 감소하였다.As a result of the test, as shown in Table 7, Table 8 and FIG. 7, the proportion of omega fatty acid in the processed meat of the finishing pigs fed on day 68 decreased compared with the control. Ham 's omega fatty acid ratio decreased from 16.23: 1 to 3.63: 1 and sausage omega fatty acid ratio decreased from 16.31: 1 to 3.8: 1.
또, 표9 및 도8에서 알 수 있듯이 68일 급여한 비육돈의 가공육 내 베타인 함량은 대조구에 비해 증가하였다. 햄의 베타인 함량은 94.28ug/g에서 290.21ug/g으로 약 3.1배 증가하였고, 소시지의 베타인 함량은 65.95ug/g에서 185.09ug/g으로 약 2.8배 증가하였다.In addition, as shown in Table 9 and FIG. 8, beta-phosphorus content in the processed meat of the finishing pigs fed on day 68 was higher than that of the control. Betaine content of ham increased 3.1 times from 94.28 ug / g to 290.21 ug / g, and beta content of sausage was increased from 65.95 ug / g to 185.09 ug / g about 2.8 times.
Fatty acid
Common ham
Fatty acid
Common ham
94.28 + - 4.94
290.21 + - 7.13
General sausage
65.95 + - 5.33
185.09 ± 5.08
시험예4. 가공육 내 오메가 지방산 및 기능성 물질 함량 분석본 발명 실시예3의 방법에 따라 아마종실과 베타인을 첨가한 사료를 33일 급여한 비육돈의 가공육 내 오메가 지방산 및 기능성 물질 함량을 확인하기 위해 GC 분석 방법과 LC-MS를 이용하여 분석하였다.Test Example 4. Analysis of Omega Fatty Acid and Functional Substance Content in Processed Meat In order to determine the content of omega fatty acid and functional material in the finishing meat of finishing pigs fed the feed containing flax seed and betaine for 33 days according to the method of Example 3 of the present invention, -MS. ≪ / RTI >
이를 평가하기 위해 상기 시험예3의 시험구2 돈육과 지방을 이용하여 햄(후지돈육 : 73.35%, 지방 : 16.29% 및 기타부재료 : 10.36%)과 소시지(후지돈육 : 53.79%, 지방 : 21.19% 및 기타부재료 : 22.02%)를 제조하여 오메가 지방산과 기능성 물질 함량을 분석하였다. 시료 내 지방산은 GC를 이용하여 분석하였고 베타인, homocysteine 및 비타민 E는 LC-MS를 이용하여 분석하였다.(Fuji pork: 73.35%, fat: 16.29% and other ingredients: 10.36%) and sausage (Fuji pork: 53.79%, fat: 21.19%) were used in the test of Example 3, And other ingredients: 22.02%) were prepared and analyzed for omega fatty acid and functional content. Fatty acids in the samples were analyzed by GC, and betaine, homocysteine and vitamin E were analyzed by LC-MS.
시험 결과, 표10에서 알 수 있듯이 33일 급여한 비육돈의 가공육 내 오메가 지방산 비율은 대조구에 비해 감소하였다. 햄의 오메가 지방산 비율은 20.1:1에서 5.2:1로 감소하였고 소시지의 오메가 지방산 비율은 20.3:1에서 5.1:1로 감소하였다.As shown in Table 10, the proportion of omega fatty acids in the processed meat of the finishing pigs fed on day 33 was lower than that of the control. The omega fatty acid ratio of ham decreased from 20.1: 1 to 5.2: 1 and the omega fatty acid ratio of sausage decreased from 20.3: 1 to 5.1: 1.
또, 도9에서 알 수 있듯이 33일 급여한 비육돈의 가공육 내 베타인 함량은 대조구에 비해 증가하였다. 햄의 베타인 함량은 119.2ug/g에서 241.5ug/g으로 약 2배 증가하였고, 소시지의 베타인 함량은 86.5ug/g에서 234.3ug/g으로 약 2.7배 증가하였다.As can be seen from FIG. 9, the content of betaine in the processed meat of the finishing pigs fed on the 33rd day was increased compared to that of the control. Betaine content of ham increased about 2 times from 119.2 ug / g to 241.5 ug / g, and beta content of sausage increased 2.7 times from 86.5 ug / g to 234.3 ug / g.
이상 설명한 바와 같이 본 발명은 아마종실과 베타인을 첨가한 사료를 급여하여 오메가 지방산의 균형과 베타인을 강화시킨 돈육 및 가공육과 그 생산방법에 관한 것이다. 오메가 지방산의 균형을 맞추고 베타인을 강화시킴으로써 비육돈의 여름철 고온 스트레스 저감효과 및 생리활성 효과를 기대할 수 있으며 돈육 내 축적시킴으로써 지방산의 균형이 맞고 베타인이 강화된 기능성 돈육을 소비자에게 전달할 수 있다. 또, 선호부위인 삼겹살 이외에 비선호부위인 후지를 이용한 가공육제품을 제공함으로써 비선호부위의 소비 진작에도 도움을 주는 뛰어난 효과가 있으므로 식품 산업상 유용한 발명일 것이다.As described above, the present invention relates to a method for producing omega fatty acid balance and betaine-reinforced pork, processed meat, and a production method thereof, by feeding a feedstuff containing flax seed and betaine. By balancing omega fatty acids and strengthening betaine, the effect of reducing stress and physiological activity during the summer can be anticipated. By accumulating pork in the pork, functional pork can be delivered to consumers with balanced fatty acids and enhanced betaine. In addition, it is an advantageous invention in the food industry because it provides an excellent effect of helping consumption of non-preferred parts by providing processed meat products using Fuji, which is a non-preferred part, in addition to the preferential part of pork belly.
Claims (5)
The method comprising the steps of: mixing 0.1% by weight of a combined feedstuff, 0.5% by weight of betaine, 2.5-5% by weight of flaxseed and 0.6% by weight of vitamin E based on the total weight of the pig feed.
A pig feed comprising the pig feed additive composition produced by the method of claim 1 in an amount of 3 to 6% by weight based on the total weight of the pig feed.
The ratio of fatty acids in the pork (ω-6 / ω-3) is reduced by 3 to 6 times and the betaine is increased by 2 to 3 times The method of production of pork characterized by that.
Pork produced by the method of paragraph 3.
Processed meat ham or sausage of the pork of paragraph 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190080880A KR20190084229A (en) | 2019-07-04 | 2019-07-04 | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190080880A KR20190084229A (en) | 2019-07-04 | 2019-07-04 | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150187693A Division KR20170077936A (en) | 2015-12-28 | 2015-12-28 | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190084229A true KR20190084229A (en) | 2019-07-16 |
Family
ID=67474375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190080880A KR20190084229A (en) | 2019-07-04 | 2019-07-04 | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190084229A (en) |
-
2019
- 2019-07-04 KR KR1020190080880A patent/KR20190084229A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Peterson et al. | Analysis of variation in cis-9, trans-11 conjugated linoleic acid (CLA) in milk fat of dairy cows | |
Schroeder et al. | Effects of fat supplementation on milk production and composition by dairy cows on pasture: a review | |
AbuGhazaleh et al. | Milk conjugated linoleic acid response to fish oil supplementation of diets differing in fatty acid profiles | |
Ponnampalam et al. | Effect of feeding systems on omega-3 fatty acids, conjugated linoleic acid and trans fatty acids in Australian beef cuts: potential impact on human health | |
AbuGhazaleh et al. | Conjugated linoleic acid increases in milk when cows fed fish meal and extruded soybeans for an extended period of time | |
Kamel et al. | Nutritional value of whole dates and date pits in broiler rations | |
EP1827127B1 (en) | Preparation and use of high omega-3 and omega-6 feed | |
Agenäs et al. | Effects of turnout to pasture and dietary fat supplementation on milk fat composition and conjugated linoleic acid in dairy cows | |
Ghasemi et al. | Effect of supplementing palmitic acid and altering the dietary ratio of n-6: n-3 fatty acids in low-fibre diets on production responses of dairy cows | |
Manning et al. | Enrichment of channel catfish (Ictalurus punctatus) fillets with conjugated linoleic acid and omega-3 fatty acids by dietary manipulation | |
US20070280998A1 (en) | Dairy product | |
Altman et al. | Utilizing industrial hemp (Cannabis sativa L.) by-products in livestock rations | |
Hukerdi et al. | Supplementing kids diet with olive leaves: Effect on meat quality | |
US20040228948A1 (en) | Increasing the concentration of conjugated linoleic acid isomers in the milk fat and/or tissue fat of ruminants | |
Abuelfatah et al. | Changes in fatty acid composition and distribution of N-3 fatty acids in goat tissues fed different levels of whole linseed | |
Adamska et al. | Milk of Polish Red and White cows as a source of nutritionally valuable fatty acids | |
KR20190084229A (en) | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof | |
Eid et al. | Effect of plant source of omega-3 fatty acids and green tea powder on the performance and meat quality of growing rabbits | |
Kholif et al. | Milk production and composition, milk fatty acid profile, nutrients digestibility and blood composition of dairy buffaloes fed crushed flaxseed in early lactation | |
KR20170077936A (en) | Balance of omega fatty acids and betaine enhanced functionality pork and processed meat production and producing method thereof | |
Omar et al. | Effect of ground flaxseed on the carcass characteristics of Karadi male lambs | |
Brzóska | Effect of dietary vegetable oils on milk yield, composition and CLA isomer profile in milk from dairy cows | |
Khiaosa-Ard et al. | Effect of inclusion of bakery by-products in the dairy cow's diet on milk fatty acid composition | |
KR20160022475A (en) | Feed composition for lactating sows nursing pig comprising conjugated linoleic acid fortifying pig lets immunity and feeding method thereof | |
US20190223477A1 (en) | Methods of increasing the omega-3 polyunsaturated fatty acids levels in human plasma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |